3D printed personalized therapies for pediatric patients affected by adrenal insufficiency
The results confirm the suitability and safety of the developed printlets for use in the clinical trial. The required technical information from The Spanish Medicines Agency for this clinical trial application was compiled to serve as guidelines for healthcare professionals seeking to apply for and conduct clinical trials on 3DP oral dosage forms.
Authors
- Carlos Javier Parramon‐Teixidó (ORCID: https://orcid.org/0000-0001-8023-3979)
- Carmen Alvarez‐Lorenzo (ORCID: https://orcid.org/0000-0002-8546-7085)
- Abdul W. Basit (ORCID: https://orcid.org/0000-0002-5368-6603)
- Lucía Rodríguez‐Pombo (ORCID: https://orcid.org/0000-0003-1028-2737)
- Álvaro Goyanes (ORCID: https://orcid.org/0000-0002-3378-6797)
- Carme Cañete-Ramírez
- M. J. Cabañas Poy (ORCID: https://orcid.org/0000-0003-2724-2715)
- Anna Kirstine Jørgensen
- Concepción Gallego-Fernández
Institutions
- Universidade de Santiago de Compostela (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Artificial Intelligence Research Institute (ES)
- Parkwood Hospital (GB)
- University College London (GB)
Publication Details
- Journal
- Expert Opinion on Drug Delivery
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1080/17425247.2024.2399706
- Citations
- 22
- Primary Topic
- Adrenal Hormones and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 7.87
Funders
- Engineering and Physical Sciences Research Council